Bullseye Brief

Pfizer Chief Economist Neal Masia on Drug Pricing, Value-Based Care and Why Blockchain Matters for Big Pharma

Informações:

Synopsis

This week, we go to Pfizer to speak with chief economist Neal Masia about what goes into drug pricing, how he uses data, and the ways newcomers like Amazon and blockchain could affect the world of pharmaceuticals.